Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Pathogens (Basel, Switzerland)|October 30, 2020
The Potential Contribution of Caveolin 1 to HIV Latent InfectionBikash Sahay, Ayalew MergiaViruses|May 24, 2018
Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 VaccineBikash Sahay, Janet K YamamotoViruses|February 26, 2025
Current Dengue Virus Vaccine Developments and Future DirectionsGovindaraj Anumanthan, Bikash Sahay, Ayalew MergiaCurrent Opinion in Chemical Biology|July 10, 2013
New generation of oral mucosal vaccines targeting dendritic cellsJennifer L Owen, Bikash Sahay, Mansour MohamadzadehJournal of Clinical & Cellular Immunology|December 12, 2017
Conserved HIV Epitopes for an Effective HIV VaccineBikash Sahay, Cuong Q Nguyen, Janet K YamamotoGut Microbes|November 10, 2012
Targeting aberrant colon cancer-specific DNA methylation with lipoteichoic acid-deficient Lactobacillus acidophilusYaíma L Lightfoot, Tao Yang, Bikash Sahay, et al.Pathogens (Basel, Switzerland)|January 28, 2026
Antiviral Role of Surface Layer Protein A (SlpA) of <i>Lactobacillus acidophilus</i>Govindaraj Anumanthan, Ananta Prasad Arukha, Ayalew Mergia, et al.Methods in Molecular Biology (Clifton, N.J.)|June 30, 2018
Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP VaccineBikash Sahay, Alek M Aranyos, Andrew McAvoy, et al.Cancer Immunology, Immunotherapy : CII|June 30, 2026
R-5780, a SagA-engineered Lactococcus lactis, is a safe oral synthetic-biology microbial therapy that potentiates PD-1 blockadeMiaki Fukuhara, Bikash Sahay, Gary R Fanger, et al.Toxins|September 25, 2015
Impact of Gastrointestinal Bacillus anthracis Infection on Hepatic B CellsNatacha Colliou, Bikash Sahay, Mojgan Zadeh, et al.Pageof 6